Amvuttra : Orphan maintenance assessment report (II-15) (post-authorisation)
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Source
European Medicines Agency
Additional Information
medication.label.product_type
orphan-maintenance-report-post
medication.label.permit_number
EMADOC-360526170-2392475
medication.label.permit_validity
First published: 2025-07-01T14:26:38Z
Documents
Related Medications
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
AI Voice
Listen to the article content live